Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Chi Leung Chiang"'
Autor:
Siu Hin Mak, Sean Man Natalie Wong, Wan Hang Keith Chiu, Chi Leung Chiang, Wing Ling Winnie Yip, Hoi Man Connie Ho, Sin Yu Cynthia Yeung, Ka Heng Mark Chan, Wan Yan Venus Lee, Ann Shing Francis Lee
Publikováno v:
Strahlentherapie und onkologie. SPRINGER HEIDELBERG
PurposeStereotactic body radiation therapy (SBRT) is a novel local therapy for the treatment of hepatocellular carcinoma (HCC). While effective, there is currently noreliable radiological marker to guide patient selection. In this study, we investiga
Autor:
S Y Yeung, Ka-On Lam, K S Lau, H C Choi, S F Lee, K K Yuen, Siok-Yee Chan, Chi-Leung Chiang, B Y Chan, TS Choy
Publikováno v:
Asia-Pacific Journal of Clinical Oncology. 15:5-13
AIM To investigate treatment patterns and outcomes of metastatic colorectal cancer (mCRC) patients beyond second progression (PD2) since regorafenib and TAS-102 became available in Hong Kong. METHODS The clinical records of consecutive mCRC patients
Autor:
Ren Ji, Kelvin K. Ng, Wenqi Chen, Weihong Yang, Hongtao Zhu, Tan-To Cheung, Chi-Leung Chiang, Tiffany C.L. Wong, Feng-Ming Kong, G. Wu, Chung-Mau Lo
Publikováno v:
Medicine
Stereotactic body radiotherapy (SBRT) is a novel noninvasive treatment for unresectable hepatocellular carcinoma (HCC). Whether its efficacy is comparable to radiofrequency ablation (RFA), a recommended therapy for unresectable HCC, is unknown. The p
Autor:
Venus W Y Lee, Cynthia S Y Yeung, Kam Sze Tsang, Natalie S. M. Wong, Connie H. M. Ho, S. K. Ha, Mark ka heng Chan, Francis A. S. Lee, Chi-Leung Chiang, B. Wang
Publikováno v:
Scientific Reports, Vol 10, Iss 1, Pp 1-10 (2020)
Scientific Reports
Scientific Reports
This study aims at evaluating the symptom response, response duration, and toxicity of single dose palliative liver radiotherapy (RT) for symptomatic HCC patients. We reviewed unresectable HCC patients treated with palliative RT in our institution. E
Autor:
Conrad Lee, Kwong Chuen Leung, Marc K. C. Chong, Steward Tung, Jacques Jolivet, Francis A. S. Lee, Maria Lai, Chi-Leung Chiang, Chloe Kwok, Philip W.K. Kwong, Steven Kin-Lok Siu, FY Cheung, Benny Zee
Publikováno v:
American Journal of Clinical Oncology. 39:609-613
Objectives This multicenter, randomized, open-label, phase II trial evaluated the efficacy and safety of AEG35156 in addition to sorafenib in patients with advanced hepatocellular carcinoma (HCC), as compared with sorafenib alone. Methods Eligible pa
Publikováno v:
Prostate cancer and prostatic diseases. 23(1)
Several randomized control trials (RCTs) have showed that adding either abiraterone acetate (AA) or docetaxel (D) to androgen-deprivation therapy (ADT) improves survival of metastatic castration-sensitive prostate cancer patients (mCSPC). Yet, the co
Autor:
Jessica W.Y. Lai, Darren M.C. Poon, James C.H. Chow, Horace C.W. Choi, Wai Tong Ng, Tin‐Ching Chau, Kwok-Hung Au, Anthony H.P. Tam, Victor Ho-Fun Lee, Chi-Leung Chiang, Edwin C.Y. Wong, Anne W.M. Lee, Alice K.W. Cheung
Publikováno v:
HeadneckREFERENCES. 41(10)
Background This study evaluates the contemporary care for patients with locally recurrent nasopharyngeal carcinoma after failure of the primary course of intensity modulated radiotherapy. Methods Eligible patients were identified through the Hong Kon
Autor:
Francis A. S. Lee, Chi-Leung Chiang, Chi Ming Poon, Stewart Y. Tung, Frank Chi Sing Wong, Yiu Wah Wong, Shing Fung Lee
Publikováno v:
Journal of the Formosan Medical Association, Vol 117, Iss 9, Pp 825-832 (2018)
Background: For advanced rectal cancer with involved or threatened mesorectal fascia (MRF), current standard is pre-operative long course chemoradiotherapy (PLCRT) with either capecitabine or 5-fluorouracil (5-FU). However, few Chinese data on its cl